Literature DB >> 2253916

Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding.

P Calès1, H Desmorat, J P Vinel, J P Caucanas, A Ravaud, P Gerin, P Brouet, J P Pascal.   

Abstract

Because several studies have suggested that beta blockers are effective in the prophylaxis of first variceal bleeding in cirrhosis, screening for oesophageal varices might be appropriate. We prospectively studied 84 cirrhotic patients without obvious evidence of large oesophageal varices and previous bleeding during a mean follow up of 16 months. At entry to the study 41 patients had no oesophageal varices and in 43 these were grade 1. The subsequent percentages of patients without large oesophageal varices were 74% at one year and 52% at two years. Univariate analysis showed that a longer duration of cirrhosis (p less than 0.05) and grade 1 oesophageal varices at entry (p less than 0.001) were predictive factors for the occurrence of large oesophageal varices, whereas, multivariate analysis showed that the initial size of the oesophageal varices (p less than 0.001), a high initial Child-Pugh score, and a smaller improvement in Child-Pugh score during the study were independent risk factors. Among patients with grades 0 and 1 oesophageal varices at the start of the study the proportions with large oesophageal varices at two years were 31% and 70% respectively. We have calculated that, accepting a maximum risk of first bleeding of 10% without prophylactic treatment, a patient without oesophageal varices should be screened endoscopically every other year, while a patient with grade 1 disease should benefit from one annual upper gastrointestinal endoscopy.

Entities:  

Mesh:

Year:  1990        PMID: 2253916      PMCID: PMC1378703          DOI: 10.1136/gut.31.11.1298

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival.

Authors:  G J Gores; R H Wiesner; E R Dickson; A R Zinsmeister; R A Jorgensen; A Langworthy
Journal:  Gastroenterology       Date:  1989-06       Impact factor: 22.682

2.  Multivariate survival analysis using Cox's regression model.

Authors:  E Christensen
Journal:  Hepatology       Date:  1987 Nov-Dec       Impact factor: 17.425

3.  Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial.

Authors:  D Lebrec; T Poynard; J P Capron; P Hillon; P Geoffroy; D Roulot; J C Chaput; B Rueff; J P Benhamou
Journal:  J Hepatol       Date:  1988-08       Impact factor: 25.083

4.  Portal hypertensive gastric mucosa: an endoscopic study.

Authors:  A Papazian; A Braillon; J L Dupas; F Sevenet; J P Capron
Journal:  Gut       Date:  1986-10       Impact factor: 23.059

5.  Gastroesophageal endoscopic features in cirrhosis. Observer variability, interassociations, and relationship to hepatic dysfunction.

Authors:  P Calès; B Zabotto; C Meskens; J P Caucanas; J P Vinel; H Desmorat; J Fermanian; J P Pascal
Journal:  Gastroenterology       Date:  1990-01       Impact factor: 22.682

6.  Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices.

Authors:  J P Pascal; P Cales
Journal:  N Engl J Med       Date:  1987-10-01       Impact factor: 91.245

7.  Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study.

Authors:  G Idéo; G Bellati; E Fesce; D Grimoldi
Journal:  Hepatology       Date:  1988 Jan-Feb       Impact factor: 17.425

8.  [Does the size of esophageal varices have a prognostic significance in alcoholic cirrhosis?].

Authors:  R E Poupon; N Thibult; J C Barbare; F Darnis; R Poupon
Journal:  Gastroenterol Clin Biol       Date:  1987-02

9.  Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy?

Authors:  T T McCormack; J Sims; I Eyre-Brook; H Kennedy; J Goepel; A G Johnson; D R Triger
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  21 in total

1.  Post-gastrectomy spleen enlargement and esophageal varices: distal vs total gastrectomy.

Authors:  Takatsugu Oida; Kenji Mimatsu; Hisao Kano; Atsushi Kawasaki; Youichi Kuboi; Nobutada Fukino; Sadao Amano
Journal:  World J Gastroenterol       Date:  2010-06-14       Impact factor: 5.742

2.  Nonsurgical Treatment of Variceal Bleeding.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-04

Review 3.  Management of portal hypertension.

Authors:  D N Samonakis; C K Triantos; U Thalheimer; D W Patch; A K Burroughs
Journal:  Postgrad Med J       Date:  2004-11       Impact factor: 2.401

Review 4.  Primary prophylaxis of bleeding from esophageal varices in cirrhosis.

Authors:  Carlo Merkel; Sara Montagnese; Piero Amodio
Journal:  J Clin Exp Hepatol       Date:  2013-09-07

Review 5.  Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.

Authors:  Agostino Colli; Juan Cristóbal Gana; Jason Yap; Thomasin Adams-Webber; Natalie Rashkovan; Simon C Ling; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2017-04-26

Review 6.  Modern management of oesophageal varices.

Authors:  P J Gow; R W Chapman
Journal:  Postgrad Med J       Date:  2001-02       Impact factor: 2.401

Review 7.  Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.

Authors:  Agostino Colli; Juan Cristóbal Gana; Dan Turner; Jason Yap; Thomasin Adams-Webber; Simon C Ling; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2014-10-01

8.  Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis.

Authors:  E Giannini; F Botta; P Borro; D Risso; P Romagnoli; A Fasoli; M R Mele; E Testa; C Mansi; V Savarino; R Testa
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

9.  Portal hemodynamics as predictors of high risk esophageal varices in cirrhotic patients.

Authors:  Mohammad-K Tarzamni; Mohammad-H Somi; Sara Farhang; Morteza Jalilvand
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

Review 10.  When endoscopic therapy or pharmacotherapy fails to control variceal bleeding: what should be done? Immediate control of bleeding by TIPS?

Authors:  Martin Rössle
Journal:  Langenbecks Arch Surg       Date:  2003-05-01       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.